Mismatched kidney transplants boost survival in seniors
NCT ID NCT07436338
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 1,819 elderly patients (aged 60+) with end-stage kidney disease to see if getting a living donor kidney transplant that is not a perfect match (ABO- or HLA-incompatible) helps them live longer compared to waiting for a compatible deceased donor. The approach uses desensitization therapy to reduce the risk of rejection. Results suggest that earlier transplantation with a mismatched kidney may improve survival for older patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE (ESRD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University College of Medicine
Seoul, Jongno-gu, 03080, South Korea
-
Yonsei University College of Medicine
Seoul, Seodaemun-gu, 03722, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the choice of anesthesia quiet the Body's surgical stress response?
- A simple blood test could spot kidney transplant rejection early
- Can your gut bacteria change how transplant drugs work?
- Blood test may take the guesswork out of transplant drug dosing
- Immunotherapy may treat skin cancer in kidney transplant patients without rejection
- Could a daily pill shield transplant patients from a common virus?